Myosin-reactive autoantibodies in rheumatic carditis and normal fetus

Clinical Immunology and Immunopathology

Volumn 87, Issue 2, 1998, Pages 184-192

  Wu, Xiaobing ^a   Liu, Bin ^a   Van Der Merwe, Pieter Luttig ^b   Kalis, Neale Nicola ^b   Berney, Seth M ^c   Young, David C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Autoantibody; Fetus; Heart; Rheumatic fever

Indexed keywords

HEART ANTIBODY; IMMUNOGLOBULIN LIGHT CHAIN; MYOSIN ANTIBODY; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ANTIBODY PRODUCING CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CROSS REACTION; FETUS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE CLONE; MOLECULAR MIMICRY; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATIC HEART DISEASE; SEQUENCE ANALYSIS; STREPTOCOCCUS PYOGENES; STRUCTURE ANALYSIS;

EID: 0031861899     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4531     Document Type: Article

References (45)

1. Eisenberg M. Rheumatic heart disease in the developing world: prevalence, prevention, and control. Eur. Heart J. 14:1993;122-128.
2. Veasy L., Tani L., Hill H. Persistence of acute rheumatic fever in the intermountain area of the United States. J. Pediatr. 124:1994;9-16.
3. Zangwill K., Wald E., Londno A. Acute rheumatic fever in western Pennsylvania: A persistent problem into the 1990's. J. Pediatr. 118:1991;561-563.
4. O'Brien, K. L. Fisher, M. Bixler, D. Ewert, D. Ballinger, S. Schwartz, B. Acute rheumatic fever (ARF) outbreak in Indiana: Where did prevention fail?, Proceedings, 36th Interscience Conference on Antimicrobial Agents
5. Jambotkar S. M., Shastry P., Kamat J. R., Kinare S. Elevated levels of IgG specific antimyosin antibodies in acute rheumatic fever (ARF): Differential profiles of antibodies to myosin and soluble myocardial antigens in ARF, acute glomerulnephritis, and group A streptococcal pharyngitis. J. Clin. Lab. Immunol. 40:1993;149-161.
6. Zabriskie J., Hsu K., Seegal B. Heart-reactive antibody associated with rheumatic fever: Characterization and diagnostic significance. Clin. Exp. Immunol. 7:1970;147-159.
7. Cunningham M., Russell S. Study of heart-reactive antibody in antisera and hybridoma culture fluids against group A streptococci. Infect. Immun. 42:1983;531-538.
8. Cunningham M. W., Antone S. M., Gulizia J. M., McManus B. M., Fishcetti V. A., Gauntt C. J. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc. Natl. Acad. Sci. USA. 89:1992;1320-1324.
9. Alvarez F. L., Neu N., Rose N. R., Craig S. W., Beisel K. W. Heart-specific autoantibodies induced by coxsackievirus B3: Identification of heart autoantigens. Clin. Immunol. Immunopathol. 43:1987;129-139.
10. Rose N. R., Wolfgram L. J., Herskowitz A., Beisel K. W. Postinfectious autoimmunity: Two distinct phases of coxsackievirus B3 induced myocarditis. Ann. N.Y. Acad. Sci. 475:1986;146-156.
11. Gauntt C. J., Arizpe H. M., Higdon A. L., Wood H. J., Bowers D. F., Rozek M. M., Crawley R. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies and myocarditis. J. Immunol. 154:1995;2983-2995.
12. Liao L., Sindwani R., Rojkind R., Factor S., Leinwand L., Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J. Exp. Med. 181:1995;1123-1131.
13. Circulation. 69:1984;204A-208A.
14. Weng N., Yu-Lee L., Sanz I., Patten B., Marcus D. Structure and Specificities of anti-ganglioside autoantibodies associated with motor neuropathies. J. Immunol. 149:1992;2518-2529.
15. Shiverick K., Thomas L., Alpert N. Purification of cardiac myosin, application to hypertrophied myocardium. Biochim. Biophys. Acta. 393:1975;124-133.
16. McMillin J., Hudson E., Buja L. Long-chain acyl-CoA metabolism by mitochondria carnitine palmitoyltransferase: A cell model for pathological studies. Methods Toxicol. 2:1993;301-309.
17. +. Int. Immunol. 7:1995;807-819.
18. Cunningham M., Russell S. Study of heart-reactive antibody in antisera and hybridoma culture fluids against group A streptococci. Infect. Immun. 42:1983;531-538.
19. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350.
20. f1.
21. H. Eur. J. Immunol. 22:1992;241-245.
22. Dale J. B., Beachey E. H. Epitopes of streptococcal M proteins shared with cardiac myosin. J. Exp. Med. 162:1985;583-591.
23. Whatmore A. M., Kapur V., Sullivan D. J., Musser J. M., Kehoe M. A. Non-congruent relationships between variation inemm. Mol. Microbiol. 14:1994;619-631.
24. Hollingshead S. K., Fischetti V. A., Scott J. R. Complete nucleotide sequence of type 6 M protein of the group A streptococcus. J. Biol. Chem. 261:1986;1677-1686.
25. Miller L., Gray L., Beachey E., Kehoe M. Antigenic variation among group A streptococcal M proteins. J. Biol. Chem. 263:1988;5668-5673.
26. Schroeder H., Wang J. Preferential utilization of conserved immunoglobulin heavy chain variable gene segments during human fetal life. Proc. Natl. Acad. Sci. USA. 87:1990;6146-6150.
27. H. J. Immunol. 142:1989;883-887.
28. Quinn A., Adderson E., Shackelford P., Carroll W., Cunningham M. Autoantibody germline gene segment encodes VH and VL regions of a human anti-streptococcal monoclonal antibody recognizing streptococcal M protein and human cardiac myosin epitopes. J. Immunol. 154:1995;4203-4212.
29. Hin situ. Mol. Immunol. 27:1990;935-940.
30. Schroeder H., Hillison J., Perlmutter R. Early restriction of the human antibody repertoire. Science. 238:1987;791-793.
31. Brezinschek H., Brezinscheck R., Lipsky P. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J. Immunol. 155:1995;190-202.
32. Yamada M., Wasserman R., Reichard B., Shane S., Caton A., Rovera G. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J. Exp. Med. 173:1991;395-407.
33. Hillson J. L., Oppliger I. R., Sasso E. H., Milner E. C., Wener M. H. Emerging human B cell repertoire, Influence of developmental stage and interindividual variation. J. Immunol. 149:1992;3741-3752.
34. Shlomchik M. J., Aucoin A. H., Pisetsky D. S., Weigert M. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. USA. 84:1987;9150.
35. H. Eur. J. Immunol. 22:1992;71-78.
36. Feeney A. J. Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences. J. Exp. Med. 172:1990;1377-1390.
37. Sanz I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J. Immunol. 147:1991;1720-1729.
38. Huang C., Stollar B. D. A majority of Ig H chain cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies. J. Immunol. 151:1993;5290-5300.
39. Weber J., Blaison G., Martin T., Knapp A., Pasquali J. Evidence that the VκIII gene usage is nonstochastic in both adult and newborn peripheral B cells and that peripheral CD5+ adult B cells are oligoclonal. J. Clin. Invest. 93:1994;2093.
40. ++. Eur. J. Immunol. 23:1993;3272-3277.
41. Bridges S. L., Lee S. K., Johnson M. L., Lavelle J. C., Fowler P. G., Koopman W. J., Schroeder H. W. Somatic mutation and CDR3 lengths of immunoglobulin κ light chains expressed in patients with rheumatoid arthritis and in normal individuals. J. Clin. Invest. 96:1995;831.
42. Carlsson L., Overmo C., Holmberg D. Selection against N-region diversity in immunoglobulin heavy chain variable regions during the development of pre-immune B cell repertoires. Int. Immunol. 4:1992;549-553.
43. HH. J. Immunol. 142:1989;4054-4061.
44. +. Int. Immunol. 3:1991;865-875.
45. HL. Scand. J. Immunol. 36:1992;349-362.